Should anthracyclines and dexrazoxane be used for children with cancer?

Elvira C. van Dalen; Henk van den Berg; Martine F. Raphaël; Huib N. Caron; Leontien C. Kremer

doi:10.1016/S1470-2045(10)70301-6

Should anthracyclines and dexrazoxane be used for children with cancer?

Elvira C. van Dalen
, Henk van den Berg
, Martine F. Raphaël
, Huib N. Caron
, Leontien C. Kremer

Research output: Contribution to journal › Letter › peer-review

16 Citations (Scopus)

Original language	English
Pages (from-to)	12-13
Number of pages	2
Journal	The Lancet Oncology
Volume	12
Issue number	1
DOIs	https://doi.org/10.1016/S1470-2045(10)70301-6
Publication status	Published - Jan 2011
Externally published	Yes

Access to Document

10.1016/S1470-2045(10)70301-6

Cite this

@article{f276b58afb764d2697dc76e3dba6a666,

title = "Should anthracyclines and dexrazoxane be used for children with cancer?",

author = "\{van Dalen\}, \{Elvira C.\} and \{van den Berg\}, Henk and Rapha{\"e}l, \{Martine F.\} and Caron, \{Huib N.\} and Kremer, \{Leontien C.\}",

note = "Funding Information: The Cochrane Childhood Cancer Group is funded by Stichting Kinderen Kankervrij (KIKA), the Netherlands. The authors declared no conflicts of interest.",

year = "2011",

month = jan,

doi = "10.1016/S1470-2045(10)70301-6",

language = "English",

volume = "12",

pages = "12--13",

journal = "The Lancet Oncology",

issn = "1470-2045",